-
EP3929300
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3929300
| EP3929300 - IMPROVED EXPORT OF OLIGOSACCHARIDES FROM BACTERIAL CELLS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 01.07.2022 Database last updated on 18.11.2024 | |
| Former | The application has been published Status updated on 26.11.2021 | Most recent event Tooltip | 24.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Chr. Hansen HMO GmbH Maarweg 32 53619 Rheinbreitbach / DE | [2021/52] | Inventor(s) | 01 /
ENGLERT, Markus 53604 Bad Honnef / DE | 02 /
JENNEWEIN, Stefan 53605 Bad Honnef / DE | 03 /
FRERIGMANN, Henning 50676 Köln / DE | 04 /
PARSCHAT, Katja 53173 Bonn / DE | 05 /
TRÖTSCHEL, Christian 50767 Köln / DE | [2021/52] | Application number, filing date | 20182737.5 | 26.06.2020 | [2021/52] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3929300 | Date: | 29.12.2021 | Language: | EN | [2021/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.11.2020 | Classification | IPC: | C12P19/04, C12P19/18, C07K14/245, C07K14/255, C07K14/26, C07K14/195, C07K14/36, C07K14/21 | [2021/52] | CPC: |
C12P19/04 (EP,KR,US);
C07K14/195 (EP);
C07K14/21 (EP);
C07K14/245 (EP);
C07K14/255 (EP);
C07K14/26 (EP);
C07K14/36 (EP);
C12N1/205 (KR);
C12N15/52 (US);
C12N15/70 (US);
C12N9/0006 (US);
C12N9/1051 (US);
C12N9/1205 (US);
C12N9/1241 (US);
C12N9/88 (US);
C12N9/90 (US);
C12P19/00 (EP);
C12P19/18 (EP,KR);
C12P19/26 (EP);
C12Y101/01271 (US);
C12Y204/01065 (US);
C12Y207/07013 (US);
C12Y402/01048 (US);
C12Y504/02008 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/31] |
| Former [2021/52] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERBESSERTER EXPORT VON OLIGOSACCHARIDEN AUS BAKTERIENZELLEN | [2021/52] | English: | IMPROVED EXPORT OF OLIGOSACCHARIDES FROM BACTERIAL CELLS | [2021/52] | French: | EXPORTATION AMÉLIORÉE D'OLIGOSACCHARIDES À PARTIR DE CELLULES BACTÉRIENNES | [2021/52] | Examination procedure | 29.06.2022 | Amendment by applicant (claims and/or description) | 29.06.2022 | Examination requested [2022/31] | 29.06.2022 | Date on which the examining division has become responsible | 19.01.2023 | Observations by third parties | Fees paid | Renewal fee | 21.06.2022 | Renewal fee patent year 03 | 22.06.2023 | Renewal fee patent year 04 | 24.06.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]WO2010142305 (JENNEWEIN BIOTECHNOLOGIE GMBH [DE], et al) [XD] 1-7 * the whole document * * examples 1-4 *; | [X]WO2015197082 (GLYCOM AS [DK]) [X] 1-7 * the whole document * * examples 1,2 *; | [XD]WO2017042382 (JENNEWEIN BIOTECHNOLOGIE GMBH [DE]) [XD] 1-7 * the whole document * * examples 3-8 *; | [X]WO2018077892 (JENNEWEIN BIOTECHNOLOGIE GMBH [DE]) [X] 1-7 * the whole document * * examples 1-3,5-9 *; | [X]WO2018165072 (DEPUY SYNTHES PRODUCTS INC [US]) [X] 1-7 * the whole document * * examples 2-4 *; | [I] - WHITNEY J. C. ET AL, "Synthase-dependent exopolysaccharide secretion in Gram-negative bacteria", TRENDS IN MICROBIOLOGY, GB, (20130201), vol. 21, no. 2, doi:10.1016/j.tim.2012.10.001, ISSN 0966-842X, pages 63 - 72, XP055751752 [I] 1,4-7 * the whole document * DOI: http://dx.doi.org/10.1016/j.tim.2012.10.001 | [A] - GUAN N. ET AL, "Recent technology development for the biosynthesis of human milk oligosaccharide", RECENT PATENTS ON BIOTECHNOLOGY, (20180601), vol. 12, pages 92 - 100, XP002785340 [A] 1-7 * the whole document * | [A] - JONES C. M. ET AL, "Efflux systems in bacteria and their metabolic engineering applications", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 99, no. 22, doi:10.1007/S00253-015-6963-9, ISSN 0175-7598, (20150912), pages 9381 - 9393, (20150912), XP036118681 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1007/s00253-015-6963-9 | by applicant | US8652808 | WO2017042382 | other | WO2017042382 | - Fluman Nir et al, "Dissection of Mechanistic Principles of a Secondary Multidrug Efflux Protein", Molecular Cell, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19000101), vol. 47, no. 5, doi:10.1016/j.molcel.2012.06.018, ISSN 1097-2765, pages 777 - 787, XP028939342 DOI: http://dx.doi.org/10.1016/j.molcel.2012.06.018 | - BIBI E, ET AL., "MDFA, AN INTERESTING MODEL PROTEIN FOR STUDYING MULTIDRUG TRANSPORT", Journal of Molecular Microbiology and Biotechnology, Karger, CH, CH , (20010401), vol. 03, no. 02, ISSN 1464-1801, pages 171 - 177, XP009064688 | - Bohn Chantal, Bouloc Philippe, "The Escherichia coli cmlA Gene Encodes the Multidrug Efflux Pump Cmr/MdfA and Is Responsible for Isopropyl-beta-D-Thiogalactopyranoside Exclusion and Spectinomycin Sensitivity", Journal of Bacteriology, (19981115), vol. 180, no. 22, doi:10.1128/JB.180.22.6072-6075.1998, pages 6072 - 6075, XP055916041 DOI: http://dx.doi.org/10.1128/JB.180.22.6072-6075.1998 | - SIGAL et al., J. Mol. Microbiol. Biotechnol., (20060000), vol. 11, no. 6, pages 308 - 317 |